Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hyperscale Data (GPUS) Research & Development (2016 - 2025)

Hyperscale Data's Research & Development history spans 16 years, with the latest figure at $3.0 million for Q4 2025.

  • Quarterly results put Research & Development at $3.0 million for Q4 2025, down 51.81% from a year ago — trailing twelve months through Dec 2025 was $4.8 million (down 56.1% YoY), and the annual figure for FY2025 was $4.8 million, down 56.1%.
  • Research & Development for Q4 2025 was $3.0 million at Hyperscale Data, up from $1.6 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $6.2 million in Q4 2024 to a low of $102000.0 in Q2 2024.
  • The 5-year median for Research & Development is $712000.0 (2022), against an average of $1.3 million.
  • Peak annual rise in Research & Development hit 456.55% in 2024, while the deepest fall reached 94.35% in 2024.
  • Year by year, Research & Development stood at $384000.0 in 2021, then skyrocketed by 115.62% to $828000.0 in 2022, then skyrocketed by 34.54% to $1.1 million in 2023, then soared by 456.55% to $6.2 million in 2024, then tumbled by 51.81% to $3.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $3.0 million, $1.6 million, and $112000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.